Bone Marrow Cell Therapies for Endothelial Repair and Their Relevance to Kidney Disease

Seminars in Nephrology

Volumn 32, Issue 2, 2012, Pages 215-223

  Yuen, Darren A ^a   Gilbert, Richard E ^a   Marsden, Philip A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiogenesis; Chronic kidney disease; Early outgrowth cell; Endothelial progenitor cell; Fibrosis; Oxidative stress

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL GROWTH; CELL LOSS; CELL MIGRATION; CELL POPULATION; CELL PROTECTION; CELL REGENERATION; CELL THERAPY; CELL TRANSPORT; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM INJURY; ENGRAFTMENT; FIBROSIS; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; TISSUE REGENERATION; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; KIDNEY DISEASES; REGENERATION; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862097878     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.02.008     Document Type: Article

References (83)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
2. Basile D.P. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 2007, 72:151-156.
3. Kang D.H., Joly A.H., Oh S.W., Hugo C., Kerjaschki D., Gordon K.L., et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001, 12:1434-1447.
4. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
5. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
6. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
7. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001, 938:221-230.
8. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001, 98:10344-10349.
9. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422-3427.
10. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000, 105:1527-1536.
11. Zhao Y.D., Courtman D.W., Deng Y., Kugathasan L., Zhang Q., Stewart D.J. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and enos gene therapy in established disease. Circ Res 2005, 96:442-450.
12. Togel F., Weiss K., Yang Y., Hu Z., Zhang P., Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007, 292:F1626-F1635.
13. Rafii S., Oz M.C., Seldomridge J.A., Ferris B., Asch A.S., Nachman R.L., et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg 1995, 60:1627-1632.
14. Grant M.B., May W.S., Caballero S., Brown G.A., Guthrie S.M., Mames R.N., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002, 8:607-612.
15. Zhang Z.G., Zhang L., Jiang Q., Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 2002, 90:284-288.
16. Uchimura H., Marumo T., Takase O., Kawachi H., Shimizu F., Hayashi M., et al. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol 2005, 16:997-1004.
17. Chade A.R., Zhu X., Lavi R., Krier J.D., Pislaru S., Simari R.D., et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009, 119:547-557.
18. Yuen D.A., Connelly K.A., Advani A., Liao C., Kuliszewski M.A., Trogadis J., et al. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One 2010, 5. e9543.
19. Sangidorj O., Yang S.H., Jang H.R., Lee J.P., Cha R.H., Kim S.M., et al. Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. Am J Physiol Renal Physiol 2010, 299:F325-F335.
20. Alexandre C.S., Volpini R.A., Shimizu M.H., Sanches T.R., Semedo P., di Jura V.L., et al. Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 2009, 27:682-692.
21. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
22. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with amd3100, a cxcr4 antagonist. J Exp Med 2005, 201:1307-1318.
23. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001, 193:1005-1014.
24. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through hif-1 induction of sdf-1. Nat Med 2004, 10:858-864.
25. Semenza G.L. Targeting hif-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732.
26. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., et al. Vegf-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
27. Hiasa K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004, 109:2454-2461.
28. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
29. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
30. Shantsila E., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007, 49:741-752.
31. Purhonen S., Palm J., Rossi D., Kaskenpaa N., Rajantie I., Yla-Herttuala S., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008, 105:6620-6625.
32. Song S., Ewald A.J., Stallcup W., Werb Z., Bergers G. Pdgfrbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005, 7:870-879.
33. Rajantie I., Ilmonen M., Alminaite A., Ozerdem U., Alitalo K., Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 2004, 104:2084-2086.
34. De Palma M., Venneri M.A., Galli R., Sergi Sergi L., Politi L.S., Sampaolesi M., et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226.
35. Ziegelhoeffer T., Fernandez B., Kostin S., Heil M., Voswinckel R., Helisch A., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004, 94:230-238.
36. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:1584-1595.
37. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
38. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
39. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000, 105:71-77.
40. Case J., Mead L.E., Bessler W.K., Prater D., White H.A., Saadatzadeh M.R., et al. Human cd34+ac133+vegfr-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007, 35:1109-1118.
41. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
42. Prater D.N., Case J., Ingram D.A., Yoder M.C. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007, 21:1141-1149.
43. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111:1302-1305.
44. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
45. Dubois C., Liu X., Claus P., Marsboom G., Pokreisz P., Vandenwijngaert S., et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 2010, 55:2232-2243.
46. Medina R.J., O'Neill C.L., Humphreys M.W., Gardiner T.A., Stitt A.W. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest Ophthalmol Vis Sci 2010, 51:5906-5913.
47. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
48. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
49. Rohde E., Malischnik C., Thaler D., Maierhofer T., Linkesch W., Lanzer G., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24:357-367.
50. Rohde E., Bartmann C., Schallmoser K., Reinisch A., Lanzer G., Linkesch W., et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 2007, 25:1746-1752.
51. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
52. Sieveking D.P., Buckle A., Celermajer D.S., Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008, 51:660-668.
53. Yang Z., von Ballmoos M.W., Faessler D., Voelzmann J., Ortmann J., Diehm N., et al. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 2010, 211:103-109.
54. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39:733-742.
55. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53:195-199.
56. Pula G., Mayr U., Evans C., Prokopi M., Vara D.S., Yin X., et al. Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures. Circ Res 2009, 104:32-40.
57. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
58. Deregibus M.C., Cantaluppi V., Calogero R., Lo Iacono M., Tetta C., Biancone L., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mrna. Blood 2007, 110:2440-2448.
59. Aicher A., Brenner W., Zuhayra M., Badorff C., Massoudi S., Assmus B., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107:2134-2139.
60. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
61. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210-1221.
62. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow-derived stem-cell transfer in patients with st-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
63. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355:1199-1209.
64. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled boost (bone marrow transfer to enhance st-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
65. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222-1232.
66. Boyle A.J., Whitbourn R., Schlicht S., Krum H., Kocher A., Nandurkar H., et al. Intra-coronary high-dose cd34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 2006, 109:21-27.
67. de Groot K., Bahlmann F.H., Sowa J., Koenig J., Menne J., Haller H., et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004, 66:641-646.
68. Choi J.H., Kim K.L., Huh W., Kim B., Byun J., Suh W., et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004, 24:1246-1252.
69. Westerweel P.E., Hoefer I.E., Blankestijn P.J., de Bree P., Groeneveld D., van Oostrom O., et al. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol 2007, 292:F1132-F1140.
70. Herbrig K., Pistrosch F., Oelschlaegel U., Wichmann G., Wagner A., Foerster S., et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004, 44:840-849.
71. de Groot K., Bahlmann F.H., Bahlmann E., Menne J., Haller H., Fliser D. Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation 2005, 79:941-945.
72. Chan C.T., Li S.H., Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005, 289:F679-F684.
73. Yuen D.A., Kuliszewski M.A., Liao C., Rudenko D., Leong-Poi H., Chan C.T. Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol 2011, 6:1345-1353.
74. Nakamura T., Torimura T., Sakamoto M., Hashimoto O., Taniguchi E., Inoue K., et al. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 2007, 133:91-107.e101.
75. Higashiyama R., Inagaki Y., Hong Y.Y., Kushida M., Nakao S., Niioka M., et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007, 45:213-222.
76. Wu L.L., Cox A., Roe C.J., Dziadek M., Cooper M.E., Gilbert R.E. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 1997, 51:1553-1567.
77. Koleganova N., Piecha G., Ritz E., Gross M.L. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol Dial Transplant 2009, 24:778-787.
78. Bi B., Schmitt R., Israilova M., Nishio H., Cantley L.G. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007, 18:2486-2496.
79. Fine L.G., Norman J.T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008, 74:867-872.
80. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:1286-1292.
81. Parfrey P.S., Harnett J.D., Barre P.E. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991, 2:2-12.
82. Okamura D.M., Himmelfarb J. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatr Nephrol 2009, 24:2309-2319.
83. Dernbach E., Urbich C., Brandes R.P., Hofmann W.K., Zeiher A.M., Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004, 104:3591-3597.